Pansec L Capsule

Pansec L Capsule contain Levosulpiride (75mg) and Pantoprazole (40mg) as active ingredients. This capsule is used to treat gastroesophageal reflux disease (acid reflux) by relieving the symptoms of acidity, like stomach pain, heartburn, or irritation.

It also helps to neutralize acid and promotes easy passage of gas to reduce stomach discomfort. It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.​

• Treatment of Gastroesophageal reflux disease (Acid reflux)

Most side effects of Pansec L Capsule do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

Common side effects include:

• Stomach pain
• Vomiting
• Diarrhea
• Nausea
• Headache
• Flatulence
• Dizziness
• Joint pain

• The dosage and treatment duration of the Pansec L Capsule are decided by the doctor according overall patient's health.
• This tablet should be taken with or without food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine.​
  

• Pansec L Capsule is a combination of two medicines such as levosulpiride and pantoprazole. In which levosulpiride known as prokinetic agent works on the upper digestive system to make the stomach and intestines flow more freely, making it easier for food to pass through the stomach.
• Also, pantoprazole is a proton pump inhibitor (PPI) which help to treat acid-related indigestion and heartburn by lowering the amount of acid production in the stomach.​​
  

• Khan, N., Ahmad, S., Uz Zaman, M., Uz Zaman, F., & Uz Zaman, N. (2023). The effectiveness and safety of Levosulpiride and Pantoprazole in treating gastro-esophageal reflux disease. South African Gastroenterology Review, 21(3). https://pmc.ncbi.nlm.nih.gov/articles/PMC1936295/
• Kaur, U., Acharya, K., Singh, A., Gambhir, I. S., & Chakrabarti, S. S. (2022). Levosulpiride associated neuroleptic malignant syndrome in an elderly patient: a tale of confusing brand names. Acta Neurologica Belgica, 122(4), 1103-1105. https://pubmed.ncbi.nlm.nih.gov/33609249/
• Pawar, P. D., Gabhe, S. Y., Potawale, S. E., & Mahadik, K. R. (2014). Validated normal phase HPTLC method for simultaneous quantification of levosulpiride and esomeprazole in capsule dosage form. International Journal of Pharmacy and Pharmaceutical Sciences, 6(2), 347-350. 
• Shivaraju, N. H., Kowmudi, G., Anoop, K., & Nagappan, K. (2019). Stability Indicating RP-HPLC Method for the Simultaneous Estimation of Pantoprazole and Levosulpiride in Pharmaceutical Dosage Form. Int. J. Pharm. Sci. Res., 10, 4949-4958.
• Khanage, S. G., Shinde, R. C., Mohite, P. B., & Deshmukh, V. K. (2013). SIMULTANEOUS ESTIMATION OF LEVOSULPIRIDE AND PANTOPRAZOLE SODIUM IN CAPSULE DOSAGE FORM BY RP-HPLC METHOD. New Frontiers in Chemistry, 22(3/4), 23. https://www.researchgate.net/publication/258393798_Simultaneous_Estimation_of_Pantoprazole_Sodium_and_Levosulpiride_in_Capsule_Dosage_Form_by_Simultaneous_Equation_Spectrophotometric_Method
• Yadav, R., Chokshi, A., & Parmar, V. (2013). Development and validation of spectrophotometric methods for simultaneous estimation of levosulpiride and pantoprazole sodium. International Journal of Pharmaceutical Frontier Research, 3(1), 54-62.